Asian Phytoceuticals PCL (BKK:APCO)

Market Cap	1.57B -18.1%
Revenue (ttm)	201.88M -1.0%
Net Income	60.46M +19.1%
EPS	0.10 +23.3%
Shares Out	600.00M
PE Ratio	26.24
Forward PE	n/a
Dividend	0.09 (3.47%)
Ex-Dividend Date	Apr 28, 2026

Volume	45,402
Open	2.600
Previous Close	2.640
Day's Range	2.600 - 2.640
52-Week Range	2.480 - 3.440
Beta	0.08
Analysts	Hold
Price Target	3.33 (+27.1%)
Earnings Date	Aug 7, 2026

About Asian Phytoceuticals PCL

Asian Phytoceuticals Public Company Limited engages in the research and development, manufacture, and distribution of healthcare and natural extracts-based beauty products in Thailand. The company offers cream and lotion products in bottles and tubes for massage to tighten the skin and reduce the desired area, and facial lotion products; and products for reverse aging, anti-aging, and longevity. It is also involved in the research on mangosteen under the project name Operation BIM. It also exports its products. The company was formerly known as...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1988
• Country: Thailand
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: APCO

Financial Performance

In 2025, Asian Phytoceuticals PCL's revenue was 200.17 million, a decrease of -5.06% compared to the previous year's 210.83 million. Earnings were 55.41 million, an increase of 1.28%.